Proteinuria is one of the most typical manifestations of kidney involvement in Systemic Lupus Erythematosus (SLE). We report the case of a 23-year-old woman with a 6-year-long history of SLE presenting with proteinuria after a three-year remission on hydroxychloroquine. Kidney histological examination showed alterations inconsistent with lupus nephritis and suggestive of hydroxychloroquine toxicity or Fabry disease. The latter was confirmed by genetic assay.
FanouriakisAKostopoulouMCheemaK, et al.
Update of the Joint European League against rheumatism and European Renal Association – European Dialysis and Transplant Association (EULAR/ERA – EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis2019;
79: 713–723.
2.
EngCMNiehausDJEnriquezALBurgertTSLudmanMDDesnickR.Fabry disease: twenty-three mutations including sense and antisense CpG alterations and identification of a deletional hot-spot in the α-galactosidase a gene. Hum Mol Genet1994;
3: 1795–1799.
3.
ShimotoriMMaruyamaHNakamuraG, et al.
Novel mutations of the GLA gene in Japanese patients with Fabry disease and their functional characterization by active site specific chaperone. Hum Mutat2008;
29: 331.
4.
De Menezes NevesPDMMachadoJRCustódioFB, et al.
Ultrastructural deposits appearing as “zebra bodies” in renal biopsy: Fabry disease?- comparative case reports. BMC Nephrol2017;
18: 157.
WuS-ZLiangXGengJZhangM-BXieNSuX-Y.Hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease in undifferentiated connective tissue disease: a case report. World J Clin Cases2019;
7: 4377–4383.
7.
Arias MartínezNBarbado HernándezFJPérez MartínGPérez de AyalaCCasal EstebanVVázquez RodríguezJJ. [
Fabry’s disease associated with rheumatoid arthritis. Multisystemic crossroads. An Med Interna2003;
20: 28–30.].
8.
McAlarneyTOginoMApostolskiSLatovN.Specificity and cross-reactivity of anti-galactocerebroside antibodies. Immunol Invest1995;
24: 595–606.
9.
MartinezPAggioMRozenfeldP.High incidence of autoantibodies in Fabry disease patients. J Inherit Metab Dis2007;
30: 365–369.
10.
MauhinWLidoveOMasatE, et al.
Innate and adaptive immune response in Fabry disease. JIMD Rep2015;
22: 1–10.
11.
Rahman P, Gladman DD, Wither J, Silver MD. Coexistence of Fabry’s disease and systemic lupus erythematosus. Clinical and experimental rheumatology 1998; 16: 475–8.
12.
Nandagudi A, Jury EC, Alonzi D, Butters TD, Hughes S and Isenberg DA. Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry’s disease. Lupus 2013: 22: 1070–1076.
13.
Waggoner T, Waggoner K, Guma M, Kim DU and Bird L. Clinical mimicry: Fabry disease masquerading as lupus?. The Journal of Musculoskeletal Medicine 2010; 27: 101.
14.
Chatre C, Filippi N, Roubille F and Pers YM. Heart involvement in a woman treated with hydroxychloroquine for systemic lupus erythematosus revealing fabry disease. The Journal of Rheumatology 2016; 43: 997–998.
